Energetic stability states in mast cell activation syndrome: operationalizing reserve, pressure, and threshold collapse
-
By
-
Richard Tellier
-
July 13, 2026
By
Richard Tellier
July 13, 2026
by Richard Tellier
July 13, 2026
KEYNOTE-B15/EV-304 demonstrated statistically significant improvements in event-free and overall survival with perioperative pembrolizumab plus enfortumab vedotin-ejfv compared with neoadjuvant gemcitabine plus cisplatin.
July 10, 2026